Literature DB >> 871071

[Pharmacokinetic studies after oral application of radioactively labelled D-penicillamine].

K Patzschke, L Wegner, H Kaller, F A Horster.   

Abstract

14C-labelled D-penicillamine was given orally to healthy test subjects in different dosages. The time course of serum activity was followed up to 5 weeks and the urinary activity was measured for 4 days. The obtained results equalled the sum of active substance and its 14C-labelled biotransformation products. The maximal serum concentration appeared about 2 hours after ingestion, the obtained concentrations being proportional to the dosis. Thereafter the concentration declined first relatively fast, then increasingly slower. From the 4th day after ingestion the half time of elimination was 8 days. The urinary excretion was dose dependent; the urinary concentration increasing with higher dosage. The later long half time of elimination corresponded to disappearance from the blood of the portion of the drug firmly getting attached to collagen and elastic tissue structures. The several weeks latency of onset of antirheumatic effect may be due to the fact that the portion of the drug getting attached to connective tissue accumulates slowly.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871071

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  5 in total

Review 1.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of D-penicillamine.

Authors:  P Netter; B Bannwarth; P Péré; A Nicolas
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

3.  Pharmacokinetics of oral tiopronin.

Authors:  M S Carlsson; T Denneberg; B M Emanuelsson; B Kågedal; S Lindgren
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  The pharmacokinetics of penicillamine in a female mongrel dog.

Authors:  R F Bergstrom; R D Kay; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

5.  The metabolism and disposition of D-penicillamine in the DA-strain rat.

Authors:  A E Pilkington; R H Waring
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Apr-Jun       Impact factor: 2.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.